Beneficient (BENFW) EBITDA (2021 - 2025)

Beneficient has disclosed EBITDA across 5 years of filings, most recently posting $19.9 million for Q4 2025.

• EBITDA for Q4 2025 came in at $19.9 million, up 327.34% year-over-year; the trailing twelve-month figure through Dec 2025 was -$49.6 million (down 381.04% YoY), and the FY2025 annual result was $50.9 million, up 102.43% from the prior year.
• EBITDA came in at $19.9 million for Q4 2025 at Beneficient, up from -$3.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $47.6 million in Q2 2024 to a low of -$1.1 billion in Q2 2023.
• The 5-year median for EBITDA is -$7.8 million (2021), against an average of -$154.0 million.
• Across the five-year window, EBITDA sank 7103.41% in 2023 and soared 327.34% in 2025, its largest moves.
• Beneficient's EBITDA stood at -$6.8 million in 2021, then increased by 24.04% to -$5.2 million in 2022, then slumped by 10402.03% to -$542.1 million in 2023, then jumped by 98.38% to -$8.8 million in 2024, then surged by 327.34% to $19.9 million in 2025.
• The last three EBITDA figures came in at $19.9 million (Q4 2025), -$3.5 million (Q3 2025), and -$65.1 million (Q2 2025), per Business Quant data.